Omrix Biopharmaceuticals, Inc. 4
4 · Omrix Biopharmaceuticals, Inc. · Filed Jun 1, 2007
Insider Transaction Report
Form 4
PRICE FREDRIC D
Director
Transactions
- Award
Common Stock, par value $0.01 per share
2007-05-31+2,000→ 7,000 total - Award
Stock Option (Right to Buy)
2007-05-31+20,000→ 0 totalExercise: $33.10Exp: 2017-05-31→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]The shares were issued as a restricted stock grant and vest on May 31, 2009.
- [F2]The shares underlying this stock option become vested and exercisable in four equal installments of 25% each on the following dates: May 31, 2008, May 31, 2009, May 31, 2010 and May 31, 2011.